APACT: Phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) versus gemcitabine (G) for surgically resected pancreatic adenocarcinoma Meeting Abstract
| Authors: | Ko, A.; Reni, M.; Riess, H.; Pelzer, U.; O'Reilly, E. M.; Winter, J.; Oh, D. Y.; Li, C. P.; Tortora, G.; Chang, H. M.; Lopez, C. D.; Tabernero, J.; Van Cutsem, E.; Philip, P.; Goldstein, D.; Berlin, J. D.; Ferrara, S.; Li, M.; Lu, B.; Romano, A.; Marks, H.; Biankin, A.; Tempero, M. A. |
| Abstract Title: | APACT: Phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) versus gemcitabine (G) for surgically resected pancreatic adenocarcinoma |
| Meeting Title: | 50th Anniversary Joint Meeting of American Pancreatic Association (APA) and Japan Pancreas Society (JPS) |
| Journal Title: | Pancreas |
| Volume: | 48 |
| Issue: | 10 |
| Meeting Dates: | 2019 Nov 6-9 |
| Meeting Location: | Maui, HI |
| ISSN: | 0885-3177 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2019-11-01 |
| Start Page: | 1464 |
| Language: | English |
| ACCESSION: | WOS:000505712800276 |
| PROVIDER: | wos |
| DOI: | 10.1097/MPA.0000000000001419 |
| Notes: | Meeting Abstract -- Source: Wos |
